Clearline Capital’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,031
Closed -$892K 135
2023
Q3
$892K Hold
14,031
0.08% 104
2023
Q2
$1.31M Hold
14,031
0.08% 83
2023
Q1
$1.12M Hold
14,031
0.17% 77
2022
Q4
$1.54M Hold
14,031
0.27% 75
2022
Q3
$2.98M Hold
14,031
0.36% 63
2022
Q2
$1.53M Hold
14,031
0.2% 78
2022
Q1
$3.14M Hold
14,031
0.36% 67
2021
Q4
$3.23M Buy
14,031
+4,246
+43% +$1.01M 0.36% 63
2021
Q3
$2.84M Buy
9,785
+7,477
+324% +$2.2M 0.27% 68
2021
Q2
$893K Hold
2,308
0.13% 97
2021
Q1
$839K Buy
+2,308
New +$975K 0.11% 79

Other funds holding CMAX

Clearline Capital's CMAX Position: Q4 2023 in Review

Clearline Capital sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q4 2023, closing a stake of 14,031 shares — an estimated $892K sold.

Clearline Capital first reported a position in CMAX in Q1 2021 and held it in 11 quarters. The position peaked at $3.23M in Q4 2021. 58 funds tracked by Wall St. Rank hold CMAX as of Q4 2023.

  • Clearline Capital reported no remaining CareMax, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Clearline Capital sold 14,031 CareMax, Inc. Class A Common Stock shares in Q4 2023, an estimated $892K.
  • Clearline Capital first reported a position in CareMax, Inc. Class A Common Stock in Q1 2021 and held it in 11 quarters.
  • Clearline Capital's CareMax, Inc. Class A Common Stock position peaked at $3.23M in Q4 2021.
  • 58 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q4 2023.

Based on Clearline Capital's 13F filing for Q4 2023, filed 14 Feb 2024.